Histone Deacetylases in Cartilage Homeostasis and Osteoarthritis

Lomeli R. Carpio, Jennifer J Westendorf

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


The involvement of the epigenome in complex diseases is becoming increasingly clear and more feasible to study due to new genomic and computational technologies. Moreover, therapies altering the activities of proteins that modify and interpret the epigenome are available to treat cancers and neurological disorders. Many additional uses have been proposed for these drugs based on promising preclinical results, including in arthritis models. Understanding the effects of epigenomic drugs on the skeleton is of interest because of its importance in maintaining overall health and fitness. In this review, we summarize ongoing advancements in how one class of epigenetic modifiers, histone deacetylases (Hdacs), controls normal cartilage development and homeostasis, as well as recent work aimed at understanding the alterations in the expression and activities of these enzymes in osteoarthritis (OA). We also review recent studies utilizing Hdac inhibitors and discuss the potential therapeutic benefits and limitations of these drugs for preventing cartilage destruction in OA.

Original languageEnglish (US)
Article number52
JournalCurrent Rheumatology Reports
Issue number8
StatePublished - Aug 1 2016


  • Chondrocytes
  • Epigenetics
  • Hdac
  • Hdac inhibitors

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Histone Deacetylases in Cartilage Homeostasis and Osteoarthritis'. Together they form a unique fingerprint.

Cite this